Actelion's focus on high unmet medical needs
| Phase | Product/ Compound | Indication | Study | Results expected |
|
IV |
Combination bosentan & sildenafil in PAH |
COMPASS-2 |
2013 |
|
|
IV |
Pediatric pulmonary arterial hypertension |
FUTURE |
2014 |
|
|
III |
Pulmonary arterial hypertension |
SERAPHIN |
Complete |
|
|
III |
Pulmonary arterial hypertension |
GRIPHON |
2014 |
|
|
III |
Digital ulcers associated with systemic sclerosis |
- |
2014 |
|
|
II |
Clostridium difficile associated diarrhea |
- |
Complete |
|
|
II |
Multiple sclerosis |
- |
Complete |
|
|
II |
Plaque psoriasis |
- |
Complete |
|
|
I |
Anti-malarial |
Malaria |
- |
- |
|
I |
CRTH2 receptor antagonist |
Asthma |
- |
- |
|
I |
Lucerastat |
Lipid storage disorders |
- |
- |
|
I |
NCE |
Immunological disorders |
- |
- |
|
I |
Macitentan |
Glioblastoma |
- |
- |
|
I |
S1P1 modulator |
Immunological disorders |
- | - |












